{"entity":{"id":"106448fa-e090-5f7a-9e22-47bbc4e5aec9","name":"DERE WILLARD H","type":"Company","kind":"company","jurisdiction":"US","identifier":"sec:0001311569","risk":"LOW","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"subsidiary":{"id":"b0a8e817-f711-5554-8bc1-37fa1c84e460","name":"Metagenomi, Inc.","type":"Company","kind":"company","identifier":"sec:0001785279"}},{"role":"director","share":null,"subsidiary":{"id":"da243f5f-5fb4-5808-b258-c3726f1bb8cb","name":"BIOMARIN PHARMACEUTICAL INC","type":"Company","kind":"company","identifier":"sec:0001048477"}},{"role":"director","share":null,"subsidiary":{"id":"4edf03d1-5dc7-5d54-bee4-8e5ea9d963bc","name":"Mersana Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001442836"}},{"role":"director","share":null,"subsidiary":{"id":"748ec5f3-ae37-5b7c-9c28-228115c35829","name":"Seres Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001609809"}},{"role":"director","share":null,"subsidiary":{"id":"6ba1394a-97c0-5b9d-9529-b52f63e198b8","name":"MPM ACQUISITION CORP","type":"Company","kind":"company","identifier":"sec:0001428522"}},{"role":"director","share":null,"subsidiary":{"id":"1f4222fc-aa61-5c82-ba50-a51aebe03896","name":"OCERA THERAPEUTICS, INC.","type":"Company","kind":"company","identifier":"sec:0001274644"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (vessels/aircraft/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing."},"source":"corpus"}